Skip to main content
. 2015 Jun 4;2015:719316. doi: 10.1155/2015/719316

Figure 4.

Figure 4

Concentration dependent decrease of VR-EPC proliferation by treatment with CTA157-2: (a) microscopic images after addition of control IgM and CTA 157-2 at different concentrations; (b) quantitative comparison of VR-EPC proliferation after addition of control IgM and CTA 157-2 as determined by BrdU incorporation; 5 experiments; ∗∗∗ P < 0.001.